| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-90 |
Sentence |
denotes |
Health, life and disability insurance and hereditary risk for breast or colorectal cancer. |
| TextSentencer_T2 |
91-273 |
Sentence |
denotes |
Fear of insurance discrimination affecting the insurance-seeker and family has been reported as the singlemost important reason why individuals choose not to undergo genetic testing. |
| TextSentencer_T3 |
274-461 |
Sentence |
denotes |
The eleven health insurers operating on the Norwegian market were mailed a questionnaire asking them to list their insurance products and evaluate two individuals' requests for insurance. |
| TextSentencer_T4 |
462-612 |
Sentence |
denotes |
The requests were constructed in order to illustrate a high genetic risk for (a) colorectal (HNPCC) and (b) breast cancer (BRCAI/BRCA2), respectively. |
| TextSentencer_T5 |
613-647 |
Sentence |
denotes |
Nine out of 11 insurers responded. |
| TextSentencer_T6 |
648-885 |
Sentence |
denotes |
While no restriction was documented concerning risk of BRCA1/BRCA2 and life insurance or disability pension, the premium paid by persons with susceptibility to HNPCC varied between the different insurers from standard to raised premiums. |
| TextSentencer_T7 |
886-1032 |
Sentence |
denotes |
The product 'critical disease' insurance was refused or obtained at normal or raised premiums in both cases, depending on the insurer in question. |
| TextSentencer_T8 |
1033-1242 |
Sentence |
denotes |
On examining personal indemnity insurance, we found that the BRCA1/BRCA2-risk individual was offered insurance at the standard premium, whereas HNPCC-risk individuals were offered a standard or raised premium. |
| TextSentencer_T9 |
1243-1313 |
Sentence |
denotes |
Only the major Norwegian insurer is in fact diverging in its policies. |
| T1 |
0-90 |
Sentence |
denotes |
Health, life and disability insurance and hereditary risk for breast or colorectal cancer. |
| T2 |
91-273 |
Sentence |
denotes |
Fear of insurance discrimination affecting the insurance-seeker and family has been reported as the singlemost important reason why individuals choose not to undergo genetic testing. |
| T3 |
274-461 |
Sentence |
denotes |
The eleven health insurers operating on the Norwegian market were mailed a questionnaire asking them to list their insurance products and evaluate two individuals' requests for insurance. |
| T4 |
462-612 |
Sentence |
denotes |
The requests were constructed in order to illustrate a high genetic risk for (a) colorectal (HNPCC) and (b) breast cancer (BRCAI/BRCA2), respectively. |
| T5 |
613-647 |
Sentence |
denotes |
Nine out of 11 insurers responded. |
| T6 |
648-885 |
Sentence |
denotes |
While no restriction was documented concerning risk of BRCA1/BRCA2 and life insurance or disability pension, the premium paid by persons with susceptibility to HNPCC varied between the different insurers from standard to raised premiums. |
| T7 |
886-1032 |
Sentence |
denotes |
The product 'critical disease' insurance was refused or obtained at normal or raised premiums in both cases, depending on the insurer in question. |
| T8 |
1033-1242 |
Sentence |
denotes |
On examining personal indemnity insurance, we found that the BRCA1/BRCA2-risk individual was offered insurance at the standard premium, whereas HNPCC-risk individuals were offered a standard or raised premium. |
| T9 |
1243-1313 |
Sentence |
denotes |
Only the major Norwegian insurer is in fact diverging in its policies. |